Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-015185
Filing Date
2023-06-09
Accepted
2023-06-09 16:17:34
Documents
1
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8629
  Complete submission text file 0000899243-23-015185.txt   10056
Mailing Address 108 DOCKSIDE CIRCLE WESTON FL 33327
Business Address
Glover Stephen C. (Reporting) CIK: 0001304406 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40505 | Film No.: 231005520

Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Issuer) CIK: 0001836056 (see all company filings)

EIN.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)